Biogen scrapped stroke drug helps patients walk independently in Phase III trial
Patients treated with Remedy Pharmaceuticals’ stroke drug were able to walk independently after 12 months in the Phase III trial.
02 October 2024
02 October 2024
Patients treated with Remedy Pharmaceuticals’ stroke drug were able to walk independently after 12 months in the Phase III trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.